Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 01)
Sildenafil Citrate Powder, For Suspension
Product Images NDC 70710-1716
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 70710-1716). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 02)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 03)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 04)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 05)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 06)
This text appears to contain some numerical values followed by the label "High Dose", "Medium Dose" and "Low Dose". Without further context, it is difficult to infer what these values represent, but it appears to be a categorization of doses.*
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 07)
Figure 7 (9e802fb6 2a6b 4d5e B292 8a3c31e26076 08)
This is a drug interaction table that shows the effect of different drugs on Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Oral Contraceptives, Ritonavir, and Saquinavir. The recommendation for change in fold change and 90% confidence interval is provided. It also shows the maximum concentration (Cmax) and area under the curve (AUC) for each drug. There is also a graph showing the change in fold change relative to Sildenafil.*
Figure 8 (9e802fb6 2a6b 4d5e B292 8a3c31e26076 09)
This text appears to be a list of interacting drugs and their effects. The drugs listed include Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin1, Doxazosin2, Doxazosin3, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavirt, saquinavirt, and Tolbutamide. The effects mentioned include INR AUC, INR Cmax, BT, AuC, Cmax, and Change relative to interacting drug alone. There is a recommendation for each drug mentioned, such as no dose adjustment needed, recommendation for co-administration, and not recommended.*
Figure 9 (9e802fb6 2a6b 4d5e B292 8a3c31e26076 10)
The text appears to be a table showing changes from a baseline measurement in meters over a 12-week study. The key indicates that the changes are related to different doses of Sildenafil medication administered three times daily. Specifically, the doses administered were 40mg, 80mg, and 20mg. It is unclear what the study was measuring or what the units of measurement represent.*
Figure 10 (9e802fb6 2a6b 4d5e B292 8a3c31e26076 11)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 12)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 13)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 14)
This appears to be a list of items related to medical equipment. The list includes a cap, a syringe adaptor, and a bottle of sildenafil for oral suspension. The last two items listed are a barrel and a plunger, which are typically components of a syringe. Based on this information, it is possible that these items are related to the administration of medication through injections.*
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 15)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 16)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 17)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 18)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 19)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 20)
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 21)
This is a description of an oral suspension medication known as Sildenafil. The recommended dosage for the medication is not available in the text, but it is stated that each bottle contains 157g of Sildenafil. The medication must be kept out of reach of children and stored below 30°C before and after reconstitution. Unused portions of the medication should be discarded after 60 days of reconstitution. The medication is distributed by Zydus Pharmaceuticals (USA) Inc. and manufactured by Cadia Healthcare Ltd in India.*
Image (9e802fb6 2a6b 4d5e B292 8a3c31e26076 22)
Sildenafil for Oral Suspension is a grape-flavored medicine that contains 10 mg of sidenafi (e cirate) when reconstituted with 90 mL water. It comes with an oral dosing syringe and a press-in bottle adaptor. The recommended dosage information is available on the package insert. Each bottle contains 1.57 g of sidenafi cirate (1.12 g sidenafi). The reconstitution directions include tapping the bottle to loosen the powder, adding 90 mL of water, shaking well before use, and discarding any unused portion 60 days after reconstitution. The medicine needs to be stored below 30°C (86°F) or in the refrigerator at 2° to 8°C (36° to 46°F) but not freeze. This medicine is distributed by Zydus Pharmaceuticals (USA) Inc from Cadia Healthcare Ltd, India. Keep it out of the reach of children.*
Figure (9e802fb6 2a6b 4d5e B292 8a3c31e26076 23)
This is a description of Sildenafil for Oral Suspension which is to be shaken well before each use. The suspension contains 10mg of sidencfi per mL when reconstituted with 90mL of water. One bottle contains 1.57g of sidencficirate (1129 sidench). The recommended dosage and prescribing information can be found in the package. Before reconstitution, it should be stored below 30°C (86°F) in the original package in order to protect it from moisture. After reconstitution, it should be stored below 30°C or in the refrigerator at 2° to 8°C. The suspension should not be frozen and any unused portion has to be discarded within 60 days of reconstitution. The Sildenafil for Oral Suspension is distributed by Zydus Pharmaceuticals (USA) Inc. and has a grape flavor.*
Figure (9e802fb6 2a6b 4d5e B292 8a3c31e26076 24)
Sildenafil for oral suspension is a grape-flavored medication that comes in a bottle containing 1.57g of sildenafil citrate when fully constituted. Each mL of the suspension contains 10 mg of sidenafil citrate when constituted with 90 mL of water. Before use, the medication should be gently shaked until it is homogeneous. The recommended dosage should be obtained from the package insert. The medication must be stored below 30°C (86°F). An oral dosing syringe and a press-in bottle adapter are included in each package. Cadia Healthcare Limited, India produces it and is distributed by Zydus Pharmaceuticals. Only approved for oral use, and keep out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
